Production Expansion — New Opportunities for Patients

We continue to implement a large-scale project to modernize enteral nutrition production.

The launch of the company’s new production capacities is scheduled for the 2nd quarter of 2026.

At present, construction of the manufacturing facilities is underway, along with preparations for the delivery of process equipment. Once operating at full capacity, the facility will be able to produce up to 3 million liters of products per year (including powdered formulas in liquid equivalent) and will fully meet the needs of the Russian tube feeding nutrition market.

Today, among enteral nutrition manufacturers, our specialized products are among the most востребованных in the country’s hospital sector. In addition, based on the results of the first half of 2025, the Nutrien brand holds a leading position in terms of hospital sales volume.

Our product portfolio includes specialized formulas for patients with a wide range of conditions, including gastritis, diabetes, stroke, chronic respiratory diseases, liver and kidney failure, oncology-related conditions, and more. We also offer nutrition solutions for healthy individuals with increased nutritional needs.

Nutrien products are used in leading medical institutions across the country, including the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, the N.V. Sklifosovsky Research Institute for Emergency Medicine, the I.I. Dzhanelidze Research Institute of Emergency Medicine in St. Petersburg, Morozov Children’s City Clinical Hospital, and other clinics.

Our products are available through pharmacy channels across Russia and are also supplied for export.